Peter, Elise
Ciano-Petersen, Nicolas Lundahl
Do, Le-Duy
Perrot, Jimmy
Ngo, Thomas
Pluvinage, John
Bartley, Christopher M.
Zorn, Kelsey C.
Miske, Ramona
Scharf, Madeleine
Villagrán-García, Macarena
Farina, Antonio
Rogemond, Véronique
Antoine, Jean-Christophe
Tranchant, Christine
Dubois, Valérie
DeRisi, Joseph L.
Pleasure, Samuel J.
Wilson, Michael R.
Gelfand, Jeffrey M.
Traverse-Glehen, Alexandra
Honnorat, Jérôme
Desestret, Virginie
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-18-RHUS-0012)
National Institute of Mental Health and Neurosciences (R01MH122471, R25MH060482)
Brain Research Foundation
Hospices Civils de Lyon
Article History
Received: 4 July 2024
Revised: 26 July 2024
Accepted: 28 July 2024
First Online: 29 August 2024
Declarations
:
: R.M. and M.S. are employees of EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany. J.L.D. and M.R.W. report being founders and paid consultants for Delve Bio, Inc., and they also receive licensing fees from CDI Labs. J.L.D. is a paid consultant for the Public Health Company and Allen & Co. M.R.W. receives unrelated research grant funding from Roche/Genentech and Novartis, and received speaking honoraria from Genentech, Takeda, WebMD, and Novartis. J. M. G. has received research support to his institution from Hoffman LaRoche for clinical trials and serves on trial steering committees for Hoffman LaRoche; research support to his institution from Vigil Neurosciences for clinical trials; and personal fees for consulting from Arialys and Ventyx Biosciences. CMB is a physician consultant for the Neuroimmune Foundation.
: The study is part of the project Gene PNS (NCT03963700) and was approved by the Institutional Review Boards of the Hospices Civils de Lyon and UCSF (13–12,236).
: A written informed consent for sample analysis, medical research, and case publication was previously obtained from all patients.